Related Experiment Videos
Penicillamine in rheumatoid arthritis
Agents and Actions. Supplements
|January 1, 1979
Summary
Penicillamine dosage requires further study for optimal clinical use. A daily dose of 375 mg between meals appears promising for better absorption and fewer side effects.
Area of Science:
- Pharmacology
- Clinical Medicine
- Rheumatology
Background:
- Penicillamine is used in clinical practice, but optimal dosage strategies are not fully established.
- Previous studies have utilized fixed dosage schedules for patient groups.
Purpose of the Study:
- To explore various penicillamine dosage schedules to identify an effective dose with a low incidence of adverse effects.
- To determine optimal penicillamine administration timing and daily dosage for clinical practice.
Main Methods:
- Observational study of patient groups on different fixed penicillamine dosage schedules.
- Evaluation of drug absorption based on administration timing (with or between meals).
Main Results:
- A total daily dose of 1500 mg of penicillamine was found to be excessive.
- Administration of penicillamine between meals suggested improved and more predictable absorption.
- A daily total dose of 375 mg administered between meals showed favorable outcomes.
- Late-onset adverse reactions suggest a potential link to total cumulative dose.
Conclusions:
- Further research is needed to optimize penicillamine use in clinical settings.
- Lower daily doses, such as 375 mg between meals, may be more effective and safer.
- Understanding the relationship between cumulative dose and adverse reactions is crucial for patient safety.